ARTICLE
Received 6 Jun 2012 | Accepted 31 Jan 2013 | Published 12 Mar 2013
Mattias Rickhag1,*, Freja Herborg Hansen1,*, Gunnar Srensen1,2, Kristine Nrgaard Strandfelt1, Bjrn Andresen1, Kamil Gotfryd1, Kenneth L. Madsen1, Ib Vestergaard-Klewe1, Ina Ammendrup-Johnsen1, Jacob Eriksen1,Amy H. Newman3, Ernst-Martin Fchtbauer4, Jesus Gomeza5, David P.D. Woldbye2, Gitta Wrtwein2,6& Ulrik Gether1
The dopamine transporter mediates reuptake of dopamine from the synaptic cleft. The cellular mechanisms controlling dopamine transporter levels in striatal nerve terminals remain poorly understood. The dopamine transporters contain a C-terminal PDZ (PSD-95/ Discs-large/ZO-1) domain-binding sequence believed to bind synaptic scaffolding proteins, but its functional signicance is uncertain. Here we demonstrate that two different dopamine transporter knock-in mice with disrupted PDZ-binding motifs (dopamine transporter-AAA and dopamine transporter Ala) are characterized by dramatic loss of dopamine transporter
expression in the striatum, causing hyperlocomotion and attenuated response to amphetamine. In cultured dopaminergic neurons and striatal slices from dopamine transporter-AAA mice, we nd markedly reduced dopamine transporter surface levels and evidence for enhanced constitutive internalization. In dopamine transporter-AAA neurons, but not in wild-type neurons, surface levels are rescued in part by expression of a dominant-negative dynamin mutation (K44A). Our ndings suggest that PDZ-domain interactions are critical for synaptic distribution of dopamine transporter in vivo and thereby for proper maintenance of dopamine homoeostasis.
1 Molecular Neuropharmacology Laboratory, Lundbeck Foundation Center for Biomembranes in Nanomedicine, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 2 Laboratory of Neuropsychiatry, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 3 National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, Baltimore, Maryland 21224, USA. 4 Department of Molecular Biology, Aarhus University, Aarhus, Denmark. 5 Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany. 6 Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. * These authors contributed equally to this work. Correspondence and requests for materials should be addressed to U.G. (email: mailto:[email protected]
Web End [email protected] ).
NATURE COMMUNICATIONS | 4:1580 | DOI: 10.1038/ncomms2568 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 1
& 2013 Macmillan Publishers Limited. All rights reserved.
DOI: 10.1038/ncomms2568
A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2568
Dopamine has an important role in modulating motor activity, cognition, neuroendocrine functions and reward mechanisms. Aberrant dopaminergic signalling is
involved in several CNS disorders, including schizophrenia, attention-decit hyperactivity disorder, drug addiction and Parkinsons disease13. The presynaptic dopamine transporter (DAT), is responsible for sequestering released dopamine from the synaptic cleft3. Moreover, the transporter represents the major target for psychostimulants, such as cocaine and amphetamine4. Characterization of mice with genetic deletion of DAT expression (DAT KO) has demonstrated that DAT is fundamental for spatio-temporal regulation of synaptic dopamine. DAT KO mice exhibit a hyperdopaminergic state with prolonged dopamine clearance and profound alterations of extracellular dopamine dynamics5. The behavioural manifestations in DAT KO mice include locomotor hyperactivity, endocrine decits and impaired psychostimulant response5,6.
It remains unresolved how dopaminergic neurons ensure proper DAT levels in the plasma membrane of the presynaptic dopaminergic terminals. Recent efforts have identied several DAT-associated proteins, consistent with DAT being part of a multi-protein network responsible for controlling the subcellular distribution of DAT7. Interestingly, DAT contains, at its extreme C-terminus, a PDZ (PSD-95/Discs-large/ZO-1) homology-binding sequence, shown to bind the PDZ domain of PICK1 (protein interacting with C kinase 1)8. PDZ domains are modular proteinprotein interaction domains found in scaffolding proteins and known to have key roles in assembly of large multi-protein complexes, as well as in regulating trafcking of binding partners911. The interaction between PICK1 and DAT was originally proposed to be important for endoplasmic reticulum (ER) export of DAT, because C-terminal truncations of DAT resulted in ER retention and impaired surface expression of DAT in heterologous cell lines12. However, we later demonstrated that the PDZ-binding sequence of DAT is neither necessary nor sufcient for DAT surface expression in heterologous cells13. Thus, the cellular and physiological importance of DAT PDZ domain interactions in vivo has remained unclear.
Here, we investigate the signicance of the C-terminal PDZ domain-binding sequence for DAT function in vivo by generating DAT knock-in mice with disrupted PDZ domain-binding sequences. To disrupt any possible PDZ domain interactions, we rst substitute the PDZ-target sequence (LLV) with alanine residues (DAT-AAA). The disruption has major consequences for distribution of the transporter with 8090% decrease in transporter levels in striatal terminals of dopaminergic neurons, without interfering with folding and ER export of the transporter. In agreement with unique alterations in dopaminergic signalling, this change in DAT distribution causes signicant behavioural changes and attenuated amphetamine sensitivity. Further support for an indispensable role of the PDZ-binding sequence for striatal DAT distribution is obtained in a second DAT knock-in mouse in which PDZ domain interactions are disrupted through addition of a single C-terminal alanine (DAT Ala). Remarkably,
corresponding changes in DAT distribution are not observed in PICK1 knock-out mice supporting that PICK1 is not critical for synaptic DAT distribution in vivo.
ResultsMutation of the DAT C-terminal PDZ-binding sequence. The human DAT contains a C-terminal PDZ-binding sequence ( LKV) that previously was shown by other investigators and by
us to interact with the PDZ domain of PICK18,13,14. Upon alanine
substitution of the last three C-terminal residues in human DAT (618620), the interaction was disrupted13. Using a uorescent polarization assay, we found that the mouse DAT C-terminus (LLV) also binds to the PICK1 PDZ domain (Fig. 1a,b)14, and that alanine substitution of the PDZ-binding sequence in mouse DAT markedly decreased the binding afnity (WT: Ki 0.68 mM;
DAT-AAA: Ki 20.1 mM) (Fig. 1b).
Reduction in striatal distribution of DAT in DAT-AAA mice. To assess the signicance of PDZ domain interactions for DAT function in vivo, we generated a DAT knock-in mouse strain expressing the DAT-AAA mutant instead of WT (Supplementary Fig. S1). Introduction of DAT-AAA did not affect transcription of the DAT gene, that is, similar mRNA levels were found in DATAAA mice and WT littermates. The mRNA levels for tyrosine hydroxylase (TH), a key enzyme in dopamine synthesis, and marker of dopaminergic neurons, were also similar in WT and DAT-AAA mice (Fig. 1c).
The cellular distribution of DAT-AAA was assessed by immunohistochemical characterization. DAT-immunoreactivity (DAT-ir) was localized predominantly to the dorsal/ventral striatum, olfactory tubercles and midbrain (substantia nigra (SN) and ventral tegmental area (VTA)) (Fig. 1d,e), conrming previous reports15,16. As expected, we observed strong DAT-ir of axonal terminals in striatum of WT mice, whereas DAT-AAA mice displayed a remarkable loss of DAT-ir. In contrast, immunolabelling of TH demonstrated dense staining of axonal bres in striatum with similar intensities in both genotypes (Fig. 1d).
In the ventral midbrain, DAT-ir was observed in perikarya and extensions of both WT and DAT-AAA mice; however, as in striatum, DAT-AAA mice showed decreased density in SN and VTA, particularly corresponding to the dendrites (Fig. 1e). TH immunolabeling showed once again intense labelling of perikarya and processes in both genotypes (Fig. 1e). Strikingly, quantication of immunoreactivity showed that DAT-ir in striatum from DAT-AAA mice was reduced to B30% of
WT, while SN and VTA showed a less pronounced decrease (SNB81% and VTA 76% of WT) (Fig. 1f). The massive loss of DAT-ir bres in DAT-AAA mice was emphasized in a sagittal view, showing midbrain projections radiating into the terminal elds of striatum (Supplementary Fig. S1). Quantication of TH-ir showed no signicant difference between genotypes (Fig. 1f).
Immunoblotting of striatal membrane preparations conrmed that DAT levels in DAT-AAA mice were dramatically reduced, whereas total TH protein was practically unaltered (Fig. 2a). The level of functional DAT in striatal membranes was investigated in radioligand-binding experiments using the DAT ligand [125I]-RTI-55. The number of maximal binding sites (Bmax) was reduced to B10% of WT without change in afnity (Fig. 2b). We also performed autoradiography using the DAT ligand, [3H]-mazindol. Whereas WT mice had a considerable density of DAT-binding sites in both striatum and midbrain, [3H]-mazindol binding was apparently absent in both striatum and midbrain of DAT-AAA mice (Fig. 2c,d). Note that the sensitivity of [3H]-mazindol autoradiography conceivably is lower than that of [125I]-RTI-55 binding. This may explain the absence of [3H]-mazindol binding in DAT-AAA mice. Levels of functional DAT in striatum were also addressed by evaluating [3H]-dopamine uptake in striatal synaptosomes. DAT-AAA mice displayed extensive, but not complete, loss of uptake capacity (Fig. 2e). Finally, we quantied the amount of surface-expressed transporters by surface biotinylation in striatal slices, where DAT-AAA levels were reduced to B8% of WT levels (Fig. 2f).
2 NATURE COMMUNICATIONS | 4:1580 | DOI: 10.1038/ncomms2568 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2568 ARTICLE
23
25
Polarization (mP)
140
100
C tvalues for DAT
C tvalues for TH
22
24
120
21
23
20
22
mDAT WT mDAT AAA
N C
80
19
21
WT........RGEVRQFTLRHWLLV
AAA......RGEVRQFTLRHWAAA
18 WT AAA
20
60 8 7 6 5 4 3 WT AAA
Log [peptide] M
DAT DAT
TH TH
DAT DAT
TH
WT AAA
WT AAA
TH
WT AAA
WT AAA
100
OD normalized to
WT (%)
***
75
***
50
Anti-DAT Anti-TH
***
25
0
Striatum SN VTA
Figure 1 | Immunohistochemical characterization of DAT-AAA mice with disrupted C-terminal PDZ-target sequence. (a) Schematic representationof mDAT topology and C-terminal sequences for WT DAT and DAT-AAA with alanine substitution of three C-terminal residues. (b) Fluorescence polarization competition binding assay on puried PICK1 using 40 nM Oregon Green-labelled human DAT peptide (13 C-terminal residues) and increasing concentration of indicated unlabelled peptides (equivalent to the 13 C-terminal residues of mDAT WT and DAT-AAA). Data are polarization values (mP) (meanss.e.m., n 3). (c) Quantitative real-time PCR of midbrain tissue from WT and DAT-AAA mice demonstrates no difference in mRNA
expression levels. Data are shown as raw cycle threshold (Ct) values for DATand TH (meanss.e.m., n 4, non-parametric MannWhitney test, P40.05).
(d,e) Representative photomicrographs of DAT-ir and TH-ir in striatum (scale bar 500 mm) and midbrain (scale bar 200 mm) from WT and DAT-AAA
mice. A substantial loss of DAT-ir is observed in DAT-AAA mice, while TH-ir displays similar intensities in both genotypes. (f) Optical densitometry was applied for semi-quantication of DATand TH levels. Mean values were calculated and values from knock-in mice were normalized to WT (meanss.e.m., Str 33%, SN 81% and VTA 76% of WT, ***Po0.001, n 5, one-way analysis of variance with post-hoc Bonferronis multiple comparison test).
In summary, our data demonstrate a pronounced reduction in the striatal levels of DAT in DAT-AAA mice, without altered activity of the transporters present.
Extensive loss of DAT in synaptic terminals from DAT-AAA. Confocal imaging of striatal sections from WT mice showed an extensive network of DAT-labelled axonal terminals in striatum with a punctate pattern, except in areas where white matter bundled and neuronal perikarya intervened (Fig. 3). Imaging of striatal sections from DAT-AAA mice revealed a prominent loss of DAT-labelled axonal terminals. In contrast, the pattern of TH labelling was similar in WT and DAT-AAA mice, demonstrating intense staining of terminals with a punctate labelling pattern of laments partially overlapping with DAT (Fig. 3a,b). DAT-ir in SN from DAT-AAA mice was predominantly localized to perikarya where the intensity was similar to that seen in WT. The neuronal processes, however, showed scarce labelling in DAT-AAA mice, while detailed micrographs from WT mice demonstrated a ramied, complex network of dendrites. Immunouorescent TH labelling of WT midbrain neurons showed
substantial overlay with DAT, and DAT-AAA mice showed a similar pattern of TH-ir as WT mice (Fig. 3c,d).
Altered behaviour of DAT-AAA mice. Behavioural and physical characteristics of experimentally naive mice were assessed using the SHIRPA primary screen procedure, which comprises several measures covering various reexes and basic sensorimotor functions (Supplementary Table S1)17. To reveal specic behavioural consequences of the mutation, we tested basal locomotion and amphetamine-induced hyperactivity. During the rst 90 min of the 4-h test session, DAT-AAA mice were hyperactive, compared with WT mice (Fig. 4a). Hyperactivity was also observed after saline injection (Fig. 4b). As expected, WT mice responded with signicant hyperactivity upon treatment with i.p. amphetamine (1, 2 or 3 mg kg 1), whereas DAT-AAA mice exhibited an attenuated amphetamine response with no signicant change in locomotor activity (Fig. 4b). We also tested the effect of 2 mg kg 1 i.p. amphetamine in the DAT-AAA mice after 2.5 h of habituation in the activity boxes. Once again there was no signicant effect of amphetamine in the DAT-AAA mice,
NATURE COMMUNICATIONS | 4:1580 | DOI: 10.1038/ncomms2568 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 3
& 2013 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2568
RTI-55 binding in
striatum normalized
to WT(%)
125 100
75
150 DAT
150 TH
WT
Optical density
(% of WT)
Optical density
(% of WT)
100
100
AAA
50
50
50
25
*
0
0 WT AAA WT AAA
0 14
Log [RTI-55] (M)
13
12
11
10
9 8
DAT
75 kDa -Tubulin
55 kDa
TH
60 kDa
-Tubulin
55 kDa
DAT
75 kDa
DA uptake in striatum
(fmol min1 per g protein)
WT
WT
50
40
40
Mazindol binding
in striatum
(fmol mg1 wet tissue)
Optical density (% of WT)
100
80 60 40 20
30
30
20
AAA
AAA
20
10
10
n.d.
*
***
0 WT AAA
0 WT AAA
0 WT AAA
Figure 2 | Assessment of DAT-binding sites and dopamine transport in DAT-AAA mice. (a) Immunoblotting conrmed a major loss of DAT expression in striatum, while TH levels were similar to WT. Upper panels, densitometric analysis of immunoblots for WT and DAT-AAA mice, *Po0.05, non-parametric MannWhitney test (meanss.e.m., n 4). Lower panels, representative immunoblots for DAT (left) and TH (right) in striatal lysates from
WTand DAT-AAA mice. (b) Competition binding experiments on striatal membranes using the high-afnity DAT ligand [125I]-RTI-55. Data are normalized to WT littermate controls (n 4). [125I]-RTI-55 binding was analysed by non-linear regression analysis using GraphPad Prism 5.0. The afnity constants
(Ki) were determined assuming one-site binding. Bmax and Kd values were obtained from the half-maximal inhibitory concentration (IC50) value estimated by assuming a sigmoidal one-site curve (One site Fit LogIC50). Bmax: WT, 29050 fmol per mg protein; DAT-AAA, 306.2 fmol per mg protein (meanss.e.m., n 4); Kd: WT, 0.127 (0.1050.154) nM; DAT-AAA, 0.334 (0.1081.062) nM (means (s.e.m. interval), n 4). (c,d) [3H]-mazindol
autoradiography shows a high density of DAT-binding sites in striatum from WT mice, while binding is absent in DAT-AAA mice (meanss.e.m., n 4).
Midbrain region shows lower density of binding sites in WT and binding is practically absent in DAT-AAA mice. (e) Extensive loss of [3H]-dopamine uptake (0.125 mM) in striatal synaptosomes from DAT-AAA mice relative to WT, *Po0.05, non-parametric MannWhitney test (meanss.e.m., n 45).
(f) Surface biotinylation of striatal slices show a dramatic loss of surface-expressed DAT in DAT-AAA mice (% of WT controls.e.m., one-sample t-test, n 3, ***Po0.001).
whereas the 2 mg kg 1 dose increased activity in WT (Fig. 4c). Consistent with the ndings in activity boxes, DAT-AAA mice showed increased locomotor activity in an open-eld test, assessed as total distance moved (Fig. 4d).
DAT-AAA surface expression is reduced in dopaminergic neurons. To investigate the cellular phenotype of DAT-AAA, we prepared postnatal midbrain cultures of dopaminergic neurons. Immunostainings of WT neurons demonstrated widespread distribution of DAT-ir in neuronal extensions, varicosities and perikarya (Fig. 5a). The immunosignal was prominently reduced in DAT-AAA neurons and appeared more localized to the somas (Fig. 5a), consistent with the DAT staining pattern observed in DAT-AAA midbrain sections (Fig. 3c). However, some DAT-ir was clearly present in the neuronal extensions as well.
To visualize surface-expressed DAT, we exploited our recently developed uorescent cocaine analogue, JHC 164, permitting labelling of correctly folded transporter in the plasma membrane of live neurons18. As previously reported for rat neurons18, we observed a specic uorescent signal in WT neurons from mice, with uniform distribution in the plasma membrane of perikarya and extensions (Fig. 5b). Labelling of DAT-AAA-derived neurons revealed less staining intensity, consistent with a substantial reduction in surface expression of DAT-AAA.
Next, we performed immunoblotting experiments on cell lysates from the dopaminergic neurons, as well as from whole brain membrane fractions of WT and DAT-AAA pups (P1P3). In whole brain lysates, both WT DAT and DAT-AAA eluted as a single B70-kDa band with no detection of smaller, immature glycoforms (Fig. 5c). Similar results were obtained from whole
brain membranes in adult WT and DAT-AAA mice (data not shown). The substantially lowered intensity of the DAT-AAA band conrmed that DAT-AAA levels are strongly reduced already at postnatal day 13 (Fig. 5c). The transporter also eluted as a single B70 kDa band in lysates from the cultured neurons, equivalent to full-length, glycosylated DAT (Fig. 5d). To validate that this DAT band corresponded to mature, fully glycosylated DAT, we treated the neuronal lysates with endoglycosidase H (Endo H) or peptide N-glycosidase F (PNGase F). Endo H selectively cleaves ER glycoforms of glycoproteins, while PNGase F cleaves all asparagine-linked oligosaccharides. Endo H treatment had no effect, suggesting that the detectable DAT has trafcked beyond ER (Fig. 5d and Supplementary Fig. S2 for positive Endo H control). In contrast and in agreement with mature glycosylation, PNGase F treatment removed the 70-kDa band and gave instead rise to a band of B45 kDa, most likely corresponding to a completely deglycosylated transporter (Fig. 5d).
Elution of DAT as a single, mature band argues against simple ER retention causing impaired synaptic distribution of DAT-AAA. To exclude the possibility that immaturely ER-retained DAT-AAA might be subject to rapid proteosomal degradation that prevents detection of the immature forms, neuronal cultures were treated with a proteosomal inhibitor, MG-132. This treatment did not give rise to detectable immature non-glycosylated bands (Supplementary Fig. S2). Additional experiments in transfected heterologous cells argued further against ER retention of DAT-AAA. Upon transfection of both HEK293 cells and N2A cells, we observed equivalent [3H]-dopamine uptake capacity (Vmax) for both
WT and DAT-AAA, with no obvious difference in Km values
4 NATURE COMMUNICATIONS | 4:1580 | DOI: 10.1038/ncomms2568 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2568 ARTICLE
Striatum
TH Merge
DAT
DAT
WT
TH Merge
AAA
WT
AAA
Midbrain
DAT
DAT
TH Merge
TH Merge
Figure 3 | Presynaptic terminals in striatum from DAT-AAA mice demonstrate substantial loss of DAT expression. (a) Axonal terminals in striatum labelled for DAT (green, Alexa-488) show dense DAT-ir in WT mice, while DAT-AAA mice display almost a complete loss of DAT-ir. Co-localization with TH (red, Alexa-568) demonstrates partial overlay in both WT and DAT-AAA mice. TH distribution demonstrates similar intensities in both genotypes with a typical punctate pattern. (b) Higher magnication images from WT mice show a typical punctate DAT labelling of presynaptic terminals in striatum, while scarce distribution is observed in DAT-AAA mice. (c) Neuronal cell bodies in SN from WTmice display intense DAT-ir in both cell soma and extensions, while labelling in DAT-AAA mice is conned mainly to the cell soma region. TH-ir shows prominent labelling of midbrain neurons in both WT and DAT-AAA mice. (d) Higher magnication images from midbrain of WT and DAT-AAA. All scale bars, 10 mm.
(Supplementary Fig. S3). This agrees with our previous observations in human DAT-AAA13 and is in contrast to the effect of C-terminal truncations, which are known to cause ER retention8,12,13,19. Of notice, this suggests that the importance of the C-terminal PDZ-binding sequence cannot be reproduced in heterologous expression systems. Altogether, we conclude that the loss of DAT-AAA in synaptic terminals is unlikely to be a consequence of misfolding and ER retention.
Increased internalization of DAT-AAA in dopaminergic neurons. A possible explanation for the dramatic loss of striatal DAT in DAT-AAA mice is a decrease in DAT-AAA surface stability leading to enhanced internalization and lysosomal degradation. Constitutive DAT internalization has been demonstrated in both transfected heterologous cells and dopaminergic neurons2022. To assess constitutive internalization, we used the uorescent cocaine analogue, JHC 164, which does not inuence
DAT trafcking and has a very slow off-rate, which makes it suitable for studying DAT internalization18. Surface-expressed DAT was labelled with JHC 164 at 4 C, followed by 1 h internalization at 37 C. Internalized, JHC 164-labelled DAT was visible as distinct intracellular vesicular structures in both DATAAA and WT neurons. These structures were not observed in 4 C controls (Fig. 6a). The internalization was clearly seen corresponding to the somas and their proximal extensions, although more difcult to identify in the distal thin extensions. Interestingly, the constitutive internalization appeared intense in many of the DAT-AAA neurons compared with the low intensity of the surface labelling. Accordingly, we quantied the internalized fraction and conrmed that a signicantly larger fraction of DAT-AAA was internalized compared with WT DAT (Fig. 6b). We showed previously that constitutively internalized WT preferentially sorts to lysosomes in rat dopaminergic neurons23. To investigate the fate of internalized DAT-AAA, we visualized internalized JHC 164-labelled DAT in the presence
NATURE COMMUNICATIONS | 4:1580 | DOI: 10.1038/ncomms2568 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 5
& 2013 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2568
5,000
***
4,000
***
No. of beam breaks
No. of beam breaks
4,000
WT DAT-AAA
***
WT
3,000
3,000
DAT-AAA
#
2,000
2,000
*
1,000
1,000
0
0 30 60 90 150
180
120 Time (min)
210
240
0 Saline Amphetamine i.p. (mg kg1)
2
15,000 WT
#
*
DAT-AAA
*
No. of beam breaks
**
Distance moved (cm)
10,000
#
10,000
5,000
0 Saline
Amphetamine i.p. (mg kg1)
25,000
20,000
15,000
5,000
1 2 3
0 WT AAA
Figure 4 | Basal and amphetamine-induced locomotion. (a) Four hours basal locomotion. Mice were placed in an activity box and locomotion was measured as total beam breaks in 30 min bins. Data are meanss.e.m., *Po0.05, ***Po0.001, Bonferroni post-hoc t-tests after signicance in a two-way analysis of variance (ANOVA), F(7,175) 7.5; Po0.001; nWT 14, nAAA 13. (b) Amphetamine-induced hyperactivity. Locomotion was evaluated as total
beam breaks during 1 h. Data are meanss.e.m., #Po0.05, versus corresponding WT, Bonferroni post-hoc t-tests after signicant two-way ANOVA, F(3,91) 5.58; Po0.01. ***Po0.001 versus own saline group after signicant one-way ANOVA; WT (F(3,26) 23.5; Po0.001); nWT 79, nAAA 910.
(c) Amphetamine-induced hyperactivity after habituation. Locomotor activity is presented as total beam breaks during 2.5 h (meanss.e.m), #Po0.05 versus corresponding WT, Bonferroni post-hoc t-tests after signicant two-way ANOVA, F(1,27) 11.12; Po0.01. ***Po0.001 versus own saline group,
Students t-test versus WT/saline, t(11) 5.88, nWT 67, nAAA 9. (d) Basal locomotion in open-eld during 30 min. Mice were placed in the centre of an
open eld and locomotion was measured as total distance moved. Data are meanss.e.m., **Po0.01, t(19) 3.4; nWT 11, nAAA 10.
WT
AAA
DAT
JHC 164
Transmission
Overlay
DAT AAA
75 kDa
50 kDa
WT
75 kDa
50 kDa
-Actin
WT
AAA AAA
WT
Band intensity
(% of WT)
150
100
50
0 WT AAA
WT AAA
**
PNGase EndoH
+ +
+
+
Figure 5 | Dopaminergic neurons show reduced DAT-AAA surface expression and no ER retention of DAT-AAA. (a) Visualization of DAT in dopaminergic neurons from WT and DAT-AAA mice by immunostaining and confocal microscopy. DAT-AAA labelling intensity was dramatically reduced compared with WTDAT. Labelling was most intense in somas, but DAT-AAA was clearly present in extensions as well. Images are representative stainings of three independently prepared cultures. (b) Confocal live imaging of midbrain neurons derived from WT or DAT-AAA mice. Neurons were stained with the uorescent cocaine analogue, JHC 164 (10 nM), to obtain specic labelling of endogenously expressed WT and DAT-AAA present in the plasma membrane. Neurons from DAT-AAA mice exhibited markedly reduced surface labelling. Pictures are representative for three independently prepared cultures. Scale bars, 10 mm. (c) Immunoblotting of membrane fractions derived from whole brains of new born pups (P1P3). Left panel, representative immunoblot. A single DAT band (B70 kDa) is detected in membrane fractions from both WT and DAT-AAA pups, albeit with markedly reduced intensity for DAT-AAA. Note that no immature DAT bands were detected in either genotype. Right panel, densitometric analysis of immunoblots shown as % of
WT, meanss.e.m., **Po0.01, one-sample t-test. (d) Endo H and PNGase F treatment of neuronal lysates. Immunoblotting of lysates from cultured dopaminergic neurons likewise show that untreated lysates give rise to a single DAT band (B70 kDa), for both WT and DAT-AAA, with no detectable immature bands. Both the WT and the DAT-AAA bands are insensitive to Endo H treatment, but elutes at B45 kDa after deglycosylation by PNGase F (n 3).
6 NATURE COMMUNICATIONS | 4:1580 | DOI: 10.1038/ncomms2568 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2568 ARTICLE
JHC 164, 1 h 37 C Transmission, 1 h 37 C JHC 164, 1 h 4 C WT
AAA
WT
0.4
Fraction of internalized
JHC 164
0.2
0.1
0.0
*
0.3
AAA
WT
AAA
Surface Total input
WT
AAA
JHC 164, 1 h 37 C Lysotracker Overlay
WT
AAA
37 C 37 C
4 C 4 C
50
Internalized fraction (%)
40
*
30
20
10
0
WT AAA
Figure 6 | Visualization of constitutive DAT internalization in WT and DAT-AAA neurons. (a) Visualization of constitutive internalization of DAT in WT and DAT-AAA neurons by confocal live imaging using the uorescent cocaine analogue, JHC 164. Left panels, surface-expressed DAT was labelledby incubation of neurons with 10 nM JHC 164 at 4 C, followed by 1 h incubation at 37 C to allow internalization. Middle panels, transmission image.
Right panels, 4 C temperature control for internalization. Fluorescence is shown on a grey scale with the highest uorescence represented by the darkest pixels. Internalization of DAT/JHC 164 complexes is seen as JHC 164-positive vesicular structures in the neuronal soma and proximal extensions. Similar
JHC 164-positive vesicles did not appear under 4 C control conditions. Images shown were taken with identical settings to visualize the JHC 164 intensity under identical conditions for WT and DAT-AAA neurons. (b) Quantication of internalized DAT. The amount of internalized DAT was quantied relative to the total amount of JHC 164-labelled DAT and showed that a signicantly larger fraction of DAT was internalized in DAT-AAA neurons (n 20 neurons) compared with WT neurons (n 30 neurons), meanss.e.m., *Po0.05, non-parametric MannWhitney test. (c) Surface
biotinylation of striatal slices. Striatal slices were biotinylated after 1 h incubation at either 37 C to allow internalization, or at 4 C, a non-trafcking temperature control. Upper and middle panels, representative blots of WT and DAT-AAA lysates, respectively. Lysates from DAT-AAA and WTmice were run on separate gels to allow better visualization of the DAT-AAA band without reaching saturating levels of the WT band intensity. Lower panel, quantication of internalized fractions, that is, the reduction in surface levels. The internalized fraction was signicantly larger in DAT-AAA slices, meanss.e.m, *Po0.05, one-tailed t-test, n 3. (d) Co-localization between constitutively internalized JHC 164/DAT complexes and LysoTracker.
A considerable amount of co-localization with LysoTracker is seen for both WT DAT and DAT-AAA. Scale bars, 10 mm.
of the lysosomal marker, LysoTracker. Both internalized DAT-AAA and WTDAT displayed considerable co-localization with LysoTracker, indicating that also the majority of internalized DAT-AAA most likely is sorted to degradation (Fig. 6d).
To obtain further support for enhanced internalization of DAT-AAA, we rationalized that in striatal slices, striatal dopaminergic terminals would be disconnected from the somas and thereby from continuous supply of newly synthesized DAT. In turn, this should allow us to detect a putative reduction in DAT surface levels resulting from constitutive redistribution of the transporter away from the surface. Indeed, as assessed by a surface biotinylation protocol, a decrease in both WT and DATAAA surface levels could be detected in the slices after 1 h incubation at 37 C compared with incubation at a trafcking non-permissive temperature (4 C control) (Fig. 6c). Importantly,
the reduction (indicated as internalized fraction) was relatively larger in DAT-AAA striatal slices (Fig. 6c), consistent with our ndings in cultured neurons. Thus, DAT-AAA exhibits a larger redistribution to cytosolic compartments during conditions where supply of transporter to the surface is limited to the intracellular pool, present in terminals at the beginning of the experiment.
Inhibiting endocytosis rescues DAT-AAA surface expression. We hypothesized that if DAT-AAA undergoes accelerated endocytosis, inhibiting this constitutive endocytosis should rescue DAT-AAA surface levels. Constitutive DAT internalization has been shown to be clathrin/dynamin-dependent18,20. Therefore, we inhibited endocytosis using the dominant-negative dynamin mutant, K44A, previously shown to reduce DAT
NATURE COMMUNICATIONS | 4:1580 | DOI: 10.1038/ncomms2568 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 7
& 2013 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2568
internalization18,24. WT or K44A dynamin were expressed in dopaminergic neurons, using recombinant lentiviral vectors, and transduced neurons were identied by concurrent expression of enhanced green uorescent protein (EGFP). Although the transduction efciency was high, only few transduced dopaminergic neurons could be identied, underlining the general difculties in achieving heterologous expression in these neurons. Nonetheless, careful live confocal imaging, following labelling with the cocaine analogue JHC 164 to assess transporter surface levels, permitted identication of several transduced dopaminergic neurons. The imaging analysis suggested increased JHC 164 surface signal in K44A-transduced DAT-AAA neurons compared with WT dynamintransduced neurons (Fig. 7ad). This was conrmed by quantication of the surface signal by calculating the mean intensity of JHC 164 labelling of soma and proximal extensions relative to control neurons. This revealed a signicant increase in the relative surface signal of DAT-AAA in K44A-expressing
neurons, whereas no detectable effect of K44A was seen in WT neurons (Fig. 7ad).
DAT-AAA and DAT Ala phenotypes are not dependent on
PICK1. DAT and TH immunoreactivity was also investigated in an additional DAT knock-in strain, DAT Ala, where addition
of an alanine to the C-terminus disrupted interactions with PDZ domain proteins (Supplementary Fig. S4). DAT Ala mice
demonstrated a similar, though less pronounced, decrease in striatal DAT-ir concomitant with reduced labelling of neuronal processes in midbrain. TH-ir showed similar intensities in dopaminergic areas from WT and DAT Ala mice. Immuno-
blotting conrmed reduced DAT levels in striatum of DAT Ala
mice (Fig. 8ad). To determine if DAT Ala mice exhibit a
similar behavioural phenotype as DAT-AAA mice, basal locomotor activity was investigated in an open-eld test. Indeed, DAT Ala mice showed increased basal locomotion
JHC 164 Overlay
WT
EGFP
JHC 164 Overlay
EGFP
Normalized JHC 164
mean intensity
Dynamin
IRES-EGFP
(%of Dyn-wt mean)
Dynamin K44A
IRES-EGFP
60 Dyn-wt Dyn-K44A
60 Dyn-wt Dyn-K44A
AAA
Normalized JHC 164
mean intensity
Dynamin
IRES-EGFP
(% of Dyn-wt mean)
140
120
100
80
140
120
100
80
*
Dynamin K44A
IRES-EGFP
Figure 7 | Inhibition of dynamin-dependent internalization increases surface levels of DAT-AAA, but not WT. (a) Midbrain dopaminergic neurons, derived from WT pups, were transduced at day 13 in vitro with lentivirus encoding either WT dynamin or the dominant-negative K44A dynamin mutant, both coupled to EGFP expression. Left panels, JHC 164 labelling (10 nM) of surface-expressed DAT, performed 810 days after transduction, to evaluate the effect of inhibiting DAT internalization on surface expression. Middle panels, EGFP signal. Right panels, overlay of channels. (b) Quantication of JHC 164 uorescence revealed no difference between WT and K44A dynamin-transduced WT neurons, meanss.e.m. (n 34 and 38 neurons for WT
dynamin and dynamin-K44A, respectively). (c) Midbrain dopaminergic neurons, derived from DAT-AAA pups, transduced with lentivirus encoding either WT dynamin or the dominant-negative K44A dynamin mutant. Left panels, JHC 164 labelling (10 nM) of surface-expressed DAT. Middle panels,EGFP signal. Right panels, overlay of channels. (d) Inhibition of dynamin-dependent internalization, by dynamin K44A, in DAT-AAA neurons led to a signicant increase in the mean JHC 164 intensity, relative to control neurons, transduced with WT dynamin (n 25 and 26 neurons for dynamin WT and
K44A respectively, *Po0.05, non-parametric MannWhitney test). Images shown originate from at least ve independent stainings from at least four independent neuronal preparations. All images of a given genotype have been taken with identical settings for JHC 164 detection. Scale bars, 10 mm.
8 NATURE COMMUNICATIONS | 4:1580 | DOI: 10.1038/ncomms2568 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2568 ARTICLE
DAT
DAT
DAT DAT
TH TH
+Ala
DAT
WT
DAT
+Ala
WT
DAT
WT
DAT
+Ala
WT
TH TH
WT
+Ala
WT +Ala
15,000
Distance moved (cm)
150
100
Optical density
(% of WT)
***
DAT 75 kDa
-Tubulin 55 kDa
10,000
50
5,000
+Ala
*
0
0
WT +Ala
WT
+Ala
DAT DAT
WT KO
TH TH
WT KO
DAT DAT
TH TH
DAT DAT
WT KO
DAT
KO
WT KO
WT KO
DAT
WT
150
10,000
Distance moved (cm)
Optical density
(% of WT)
DAT 75 kDa
-Tubulin 55 kDa
100
8,000
6,000
50
4,000
2,000
0
WT KO
0
WT KO
Figure 8 | Immunohistochemical and biochemical characterization of DAT Ala and PICK1 KO mice. (a,b) Representative photomicrographs of
DAT-ir and TH-ir in striatum and midbrain from WTand DAT Ala mice demonstrate signicant loss of DAT-ir in mutant mice, while TH-ir displays similar
intensities between both genotypes. (c) Upper panels, confocal micrographs of axon terminals in WT and DAT Ala striatal slices labelled for DAT.
Lower panels, DAT labelling in midbrain slices. Both striatum and midbrain show substantial loss of DAT-ir in DAT Ala mice. Midbrain neurons in WT
show extensive DAT labelling in both cell bodies and dendrites, while labelling is reduced and limited to perikarya in DAT Ala mice. (d) Immunoblotting
of striatal lysates validates decreased DAT levels in striatum of DAT Ala. Left panel, densitometric analysis of immunoblots, meanss.e.m., n 4,
*Po0.05, non-parametric MannWhitney test. Right panel, representative immunoblots. (e) 30 min basal locomotion in the open-eld test. Mice were placed in the centre of an open eld and locomotion was measured as total distance moved. Data are meanss.e.m., ***Po0.001, t(19) 5.0; nWT 10,
n
Ala
11. (f,g) Representative photomicrographs from PICK1 WT and KO mice show intact DAT- and TH-ir in dopaminergic areas in KO mice.(h) Upper panels, confocal micrographs of axon terminals in striatal slices from WTand PICK1 KO mice, labelled for DAT. Lower panels, DAT labelling in WT and PICK1 KO midbrain slices. Dense DAT labelling is seen in striatum as well as midbrain of both genotypes. (i) Immunoblotting demonstrates similar striatal DAT levels in both WT and PICK1 KO mice. Left panel, densitometric analysis of immunoblots from WT and PICK1 KO mice, meanss.e.m, n 4, P40.05, non-parametric MannWhitney test. Right panel, representative immunoblots. (j) 30 min basal locomotion in the open-eld test.
Mice were placed in the centre of an open-eld and locomotion was measured as total distance moved. Data are meanss.e.m., P 0.34, t(44) 1.0;
nWT 27, n
PICK1 KO
19. Scale bars: a,f 500 mm; b,g 200 mm; c,h 10 mm.
compared with WT (Fig. 8e). To assess whether the phenotype of DAT-AAA and DAT Ala mice is related to disrupting the
interaction with PICK1, we characterized the distribution of
DAT-ir in PICK1 knock-out mice (PICK KO). DAT-ir was not reduced in these mice, neither in the striatum nor in the midbrain. This nding was also validated by immunoblotting (Fig. 8fi).
NATURE COMMUNICATIONS | 4:1580 | DOI: 10.1038/ncomms2568 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 9
& 2013 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2568
Consistently, PICK1 KO mice did not differ from WT in the open-eld test (Fig. 8j). Thus, PICK1 is not necessary for axonal distribution of DAT in striatum in vivo.
DiscussionTo assess the physiological signicance of the C-terminal PDZ-binding motif for DAT function in vivo, we generated DAT knock-in mice with modied C-termini (DAT-AAA and DAT Ala) incapable of interacting with PDZ domain proteins.
In DAT-AAA, we observed a dramatic reduction in DAT surface levels in striatal presynaptic terminals, likely resulting at least in part from enhanced constitutive endocytosis of the transporter. Moreover, we found that the decreased striatal distribution of DAT leads to unique behavioural changes, characterized by locomotor hyperactivity and impaired amphetamine response. These ndings suggest, to our knowledge for the rst time, a crucial role of specic proteinprotein interactions for synaptic distribution of DAT in vivo.
Mutations in proteins often impair folding, leading to ER retention and proteosomal degradation25. Indeed, C-terminal truncations have been shown to cause ER retention of human DAT in heterologous cells8,12,19 and it was suggested that binding of PICK1 to the DAT C-terminus was critical for ER export and DAT surface expression8. However, mutational analysis of the human DAT C-terminus showed that, although the C-terminus is critical for proper ER export, PDZ interactions are likely not involved13. Our present analysis of mouse DAT-AAA in heterologous cells further corroborated these ndings (Supplementary Fig. S3). Furthermore, the present analysis of DAT-AAA and DAT Ala mice argues against a role of the
PDZ-binding motif in ER export in vivo, despite the dramatic decrease in striatal DAT levels. It is known that poorly folded and ER-retained DAT mutants give rise to immaturely glycosylated DAT forms sensitive to Endo H13. However, for both WT and DAT-AAA mice, we were unable to detect any immaturely glycosylated DAT forms in whole brain extracts, as well as in extracts from cultured dopaminergic neurons. Such forms did not even appear when cultures were treated with the proteosomal inhibitor MG-132 (Supplementary Fig. S2). We believe that DAT-AAA is not ER retained in detectable quantities, but approved by the cellular quality control machinery and allowed to trafc beyond ER.
Previous studies demonstrated that DAT undergoes constitutive and regulated internalization, and that the C-terminal tail might be involved in regulating this trafcking7,20,26. We hypothesized accordingly that the observed reduction in synaptic and total DAT-AAA was at least in part the results of decreased surface stability of the transporter and enhanced constitutive endocytosis followed by lysosomal degradation. Importantly, we obtained evidence for a signicant increase in constitutive endocytosis of DAT-AAA compared with WTDAT in both striatal slices, using surface biotinylation and in live dopaminergic neurons, using the uorescent cocaine analogue JHC 164 (refs 7,20). Our data also showed that inhibiting constitutive endocytosis by expression of a dominant-negative dynamin mutant K44A, led to partial rescue of DAT-AAA (Figs 6 and 7). No effect was seen for WTDAT possibly because of the much higher expression and thereby different balance between membrane insertion and internalization as compared with DATAAA. Finally, we found, in agreement with our previous ndings23, a pronounced co-localization between LysoTracker and internalized WTDAT or DAT-AAA (Fig. 6), supporting that the majority of both internalized DAT and DAT-AAA is sorted to lysosomal degradation23. Correspondingly, DAT-AAA and WTDAT co-localized in part with the lysosomal marker LAMP1
in midbrain stainings (Supplementary Fig. S5). Although internalized DAT can undergo recycling7,20,27, it seems therefore reasonable to suggest that enhanced internalization and subsequent rapid degradation contribute to the DAT-AAA phenotype observed in vivo as well as ex vivo. Future studies should assess whether additional mechanisms contribute to the observed phenotypes, for example, we cannot exclude that a fraction of synthesized DAT-AAA is missorted and never reaches the presynaptic terminals before it is internalized and degraded in the somatodendritic compartment.
In addition to regulating compartmentalization and targeting2830, PDZ domain-mediated proteinprotein interactions have previously been suggested to regulate surface stability of membrane proteins3133. Reduced protein expression, but normal synaptic localization, was reported for knock-in mice lacking the PDZ-ligand motif of the metabotropic glutamate receptor mGluR7a, and hypothesized to be caused by increased turnover and degradation, in absence of stabilizing PDZ interactions34. It has also been suggested that the postsynaptic scaffolding protein, PSD-95, stabilizes the glycine transporter and the Kv1.4 potassium channel at the plasma membrane31,33.
PICK1 is the only PDZ domain protein known to bind the DAT C-terminus and the interaction has been addressed in several studies8,13,14,35. However, the present data show that the dramatic phenotype observed in both DAT-AAA and DAT Ala
mice is not observed in PICK1 KO mice, arguing that PICK1 is not responsible for maintaining DAT levels in dopaminergic nerve terminals. A remaining challenge is to identify other PDZ domain proteins that bind the DAT C-terminus. A screen of B40 different PDZ domain including several prototypical synaptic PDZ domain proteins did not identify new DAT-binding partners36; hence, further efforts are required to identify potential DAT-binding PDZ domains among an estimated total of 270 PDZ domains in 154 proteins (UniProtKB database). We nd it unlikely that the phenotypes of our knock-in mice are the result of disrupting other types of proteinprotein interactions because two very different but still PDZ-specic mutations (DAT-AAA/DAT Ala) result in similar phenotypes. Also note
that the binding of Ca2 /calmodulin-dependent protein kinase IIa to the C-terminus of DAT is unaffected by mutation of the PDZ-binding sequence37.
Our data show that the level of active DAT in DAT-AAA mice is reduced dramatically in the striatum. According to our behavioural analysis, this reduction is accompanied by a hyperactive phenotype when the mice are exposed to a new environment, consistent with increased response to novelty. However, the hyperactivity appears transient as the mice display habituation and show activity indistinguishable from WT after 2 h. This is in contrast to DAT KO mice that show only modest habituation even after several hours5. In further contrast, DAT-AAA mice show less pronounced adaptive changes, as TH expression is essentially unaltered in DAT-AAA, whereas TH levels are reduced by 90% in DAT KO38. In addition, DAT-AAA mice show no growth retardation phenotype (Supplementary Table S1). Together, our data imply that the function of the residual transporters in DAT-AAA is sufcient for maintaining a closer to normal homoeostasis within the dopaminergic system. It is also interesting to compare the DAT-AAA mice with DAT-knock-down (DAT KD) mice expressing B10% of WT
DAT levels39. DAT KD mice are hyperactive upon exposure to a novel environment and characterized by an equivalent modest habituation decit similar to DAT-AAA and show no sign of endocrine decits39. However, DAT KD and DAT-AAA mice show a difference in their response to amphetamine. Whereas amphetamine fails to induce hyperlocomotion in DAT-AAA mice, it inhibits locomotor activity in DAT KD mice similar to
10 NATURE COMMUNICATIONS | 4:1580 | DOI: 10.1038/ncomms2568 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2568 ARTICLE
what is seen in DAT KO mice39. We have no immediate explanation for the differential effect of amphetamine. However, whereas the reduced DAT levels in DAT KD mice are caused by defective transcription39, the DAT-AAA phenotype is related to changed turnover of translated protein, which may have differential functional consequences.
Summarized, we have generated two new mouse DAT models that together strongly support an indispensable role of a C-terminal PDZ-binding sequence in vivo. Furthermore, these two new mouse models are characterized by unique dopaminergic phenotypes and represent thereby novels tools for further dissecting the relationship between dopaminergic dysfunction and CNS disorders.
Methods
Site-directed mutagenesis. Constructs were generated as described in Supplementary Methods.
Fluorescence polarization assay. Experiments were performed as previously described14.
Mouse genetics. Mutant alleles with modied C-termini were generated in CJ7 ES cells using the knock-in approach40 as described (Supplementary Methods, Supplementary Figs S1 and S5). The PICK1-decient mice were kindly provided by Dr Richard Huganir (Johns Hopkins University, Baltimore, USA). All mice experiments were performed in accordance with guidelines of the Danish Animal Experimentation Inspectorate (permission number: 2012/561-142).
Quantitative real-time PCR. Assay was carried out as described in Supplementary Methods.
Immunohistochemistry. Adult mice were transcardially perfused with 4% paraformaldehyde in 0.1 M PBS pH 7.4. Coronal and sagittal sections (40 mm) were generated from striatum and midbrain. For bright-eld immunohistochemistry,a standard peroxidase-based method using 3,30-diaminobenzidine was used as previously described41. The following primary antibodies were used: rat anti-DAT antibody (MAB369 1:1,000, Millipore, USA) or rabbit polyclonal anti-TH antibody (1:1,000, Afnity Bioreagents, USA).
Co-localization studies of DAT-ir neurons were performed using dual-labelling immunouorescence. Sections were incubated overnight with rat anti-DAT antibody (1:1,000) and either rabbit anti-TH antibody (1:1,000) or rabbit polyclonal LAMP1 (1:200, Abcam). The following day sections were rinsed and incubated with Alexa Fluor 488 goat anti-rat IgG (for DAT) and Alexa Fluor 568 goat anti-rabbit IgG (for TH and LAMP1) conjugated secondary antibodies for1 h (Molecular Probes, USA). Additional rinsing was followed by mounting of coverslips using Prolong Gold antifade reagent (Molecular Probes, USA).
Confocal microscopy. Confocal microscopy was performed as described18,23, using a Zeiss (Carl Zeiss, Germany) LSM 510 confocal laser-scanning microscope with an oil immersion 63 1.4 numerical aperture objective (Carl Zeiss). Alexa
Fluor 488 dye was excited with a 488-nm laserline from an argon-krypton laser, and detection of the emitted light was done using a 505- to 530-nm bandpass lter. Alexa Fluor 568 dye and JHC 164 were excited with a 543-nm helium-neon laser and uorescence was recorded using a 560-nm long-pass lter. Images were analysed with ImageJ software.
Quantication of optical density. Optical densitometry was applied for semi-quantication of DAT and TH immunoreactivity and performed as described in Supplementary Methods.
Glial coating. Astrocytes cultures from mouse cortex were made and maintained as previously described42. 5-uorodeoxyuridine was added, when density reached 70%, approximately after 5 days.
Primary cultures of midbrain dopaminergic neurons. Postnatal dopaminergic neurons from WT and DAT-AAA mice were obtained and cultured as described18. Neurons were plated on glial-coated coverslips (B200,000 cells per slide) for immunocytochemistry and in glial-coated 2-well LabTek chambers for live imaging (B100,000 cells per well). Experiments were performed after culturing 714 days in vitro.
Immunocytochemistry. Dopaminergic neurons, grown on glia-coated coverslips, were treated as described43, though permebilization was done in PBS containing 5% goat serum and 0.2% saponin for 20 min. Primary rat anti-DAT antibody (MAB369 1:1,000) and secondary Alexa Fluor 488 (goat anti-rat IgG) (1:500) were used to visualize DAT.
Lentivirus production and transduction. Lentiviral vectors encoding GFP-tagged WT and dominant-negative (K44A) dynamin (pFUGW-IRES-GFP Dynamin K44A or pFUGW-IRES-GFP Dynamin) were kindly provided by Dr Rosalind A Segal (Harvard Medical School, Boston, MA), and produced as described18. Dopaminergic neurons were transduced at day 13 in vitro and experiments were performed 710 days after infection.
Live imaging of dopaminergic neurons. Surface-expressed DAT was visualized in live ventral midbrain dopaminergic neurons, transduced as well as untransduced, as described18, using 10 nM JHC164 for 20 min at room temperature to stain DAT.
The effect of inhibiting dynamin-dependent endocytosis on DAT surface levels was evaluated by quantifying mean JHC 164 labelling intensity of WT and DAT-AAA neurons, transduced with pFUGW-IRES-GFP Dynamin K44A or pFUGW-IRES-GFP WT Dynamin as control. Transduced neurons were identied from the coupled EGFP expression. Excitation and recording of JHC 164 uorescence (see confocal microscopy) was carried out using identical settings for all pictures taken of a given genotype, but differences in expression made it necessary to use different settings for WT and DAT-AAA neurons. A region of interest (ROI), containing the neuronal soma and proximal extensions, was manually selected on single confocal sections. The mean intensity of JHC 164 labelling within this ROI was quantied as the mean pixel intensity divided by the area percentage with JHC 164 signal, using the same threshold for all images of a given genotype.
Internalization of DAT in live WT and DAT-AAA neurons was assessed as described18, using 10 nM JHC 164 to label surface DAT at 4 C before 1 h internalization at 37 C (or 4 C as a temperature control). The neuronal soma and proximal extensions was manually selected on single confocal sections (ROI-total). The cytoplasmic region of ROI-total (that is, excluding the plasma membrane) was subsequently manually dened (ROI-internalized). Threshold was set as twice the mean intensity within ROI-total, to ensure that only specic JHC 164 signal contributed to the quantication. The total integrated JHC 164 intensity within ROI-total was taken as a measure of the entire labelled DAT pool, while the total integrated JHC 164 intensity within ROI-internalized was taken as a measureof internalized DAT/JHC 164. The internalized fraction of DAT/JHC 164 complexes was obtained as the ratio between the internalized JHC 164 and the total JHC 164. Of notice, differences in expression made it necessary to use images taken with different settings for quantication of WT and DAT-AAA internalization.
For LysoTracker co-localization studies, internalized DAT was visualized as described above, adding LysoTracker green (100 nM; Molecular Probes) in the last 15 min of incubation to visualize lysosomes. Neurons were washed twice in uptake buffer before imaging.
Membrane and whole-cell lysate preparations. Preparation of membrane fractions from adult mice striata and whole pup brains is described in Supplementary Methods, along with the preparation of whole-cell lysates from adult mice striata (for estimations of total TH expression) and whole-cell lysates from cultured dopaminergic neurons.
Brain slice preparation and surface biotinylation. Experiments were performed as described in Supplementary Methods, modied from ref. 44.
Immunoblotting. Immunoblotting was performed as described in Supplementary Methods.
Dopamine uptake in vitro. Uptake experiments were performed as described in Supplementary Methods.
Striatal membrane binding assay. Competition binding assays were performed on striatal membrane preparations, using the DAT ligand, [125I]-RTI-55 (2,200 Ci per mmol, Perkin Elmer, USA). Membrane suspensions were mixed with B1 nM [125I]-RTI-55 in a total volume of 500 ml and samples were incubated in binding buffer containing 25 mM HEPES pH 7.4, 120 mM NaCl, 5 mM KCl,1.2 mM CaCl2, 1.2 mM MgSO4 for 2 h at 4 C with constant shaking. To avoid unspecic binding of RTI-55 to the serotonin and norepinephrine transporters, 50 nM s-citalopram and 100 nM desipramine were included. The assay was terminated with ice-cold binding buffer, followed by loading of membranes on glass microber lters (GF/C Whatman). Filters were rinsed in ice-cold binding buffer and allowed to dry before scintillation uid was added and samples were counted 1 h thereafter. Non-specic binding was assessed in the presence of 1 mM
NATURE COMMUNICATIONS | 4:1580 | DOI: 10.1038/ncomms2568 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 11
& 2013 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2568
dopamine. Binding data were analysed by non-linear regression analysis assuming one-site binding (GraphPad Prism 5.0).
Autoradiography. Assay was performed as described in Supplementary Methods.
Synaptosomal dopamine uptake. Striata were dissected out from coronal slices and homogenized in ice-cold HEPES buffer (4 mM, pH 7.4) containing 0.32 M
sucrose. Crude synaptosome fraction (P2) was obtained as described in membrane preparations (Supplementary Methods) and dopamine uptake was performed with minor modications45. Unlabelled dopamine (0.125 mM) was added together with [3H]-Dopamine (Perkin Elmer Life Sciences, USA) for assessment of dopamine uptake for 5 min at 37 C. Uptake was terminated by addition of ice-cold uptake buffer. Non-specic uptake was determined in the presence of 100 mM cocaine.
Synaptosomes were loaded on glass microber lters (GF/C Whatman), rinsed4 5 ml in uptake buffer and allowed to air-dry. Scintillation uid was added and
lters were agitated for 1 h followed by counting.
Behavioural phenotype assessment (SHIRPA). Behavioural and physical characteristics of experimentally naive mice were assessed using the SHIRPA primary screen procedure as described17.
Basal locomotion and amphetamine-induced hyperactivity. Using a previously described set-up46, three experiments were carried out. (1) Basal locomotor activity: the animal was placed in an activity box and the activity measured for 4 h;(2) 1 h amphetamine-induced hyperactivity after i.p. injection of amphetamine (13 mg kg 1) or saline; (3) amphetamine-induced hyperactivity (2 mg kg 1 i.p.)
for 2.5 h after habituation to the activity boxes for 2.5 h. Furthermore, basal locomotion of DAT-AAA, DAT Ala KI and PICK1 KO mice and WT littermates
was investigated in an open-eld test. The animals were placed individually in the centre of an open eld (40 40 65 cm), illuminated indirectly by four 60-W
white light bulbs, and allowed to explore the apparatus for 30 min (ref. 46). Behaviour was recorded with a camera mounted on the ceiling directly above the open eld and total distance moved was analysed using EthoVision Software (version 3.0; Noldus, The Netherlands).
Statistics. Unless otherwise stated MannWhitney non-parametric test was applied. One- or two-way analysis of variance, followed by Bonferroni post-hoc t-tests or KruskalWallis non-parametric test, were applied when comparing more than two groups. Signicance level was set at Po0.05.
References
1. Kristensen, A. S. et al. SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol. Rev. 63, 585640 (2011).
2. Gainetdinov, R. R. & Caron, M. G. Monoamine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol. 43, 261284 (2003).
3. Torres, G. E. & Amara, S. G. Glutamate and monoamine transporters: new visions of form and function. Curr. Opin. Neurobiol. 17, 304312 (2007).
4. Sulzer, D., Sonders, M. S., Poulsen, N. W. & Galli, A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406433 (2005).
5. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M. & Caron, M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606612 (1996).
6. Bosse, R. et al. Anterior pituitary hypoplasia and dwarsm in mice lacking the dopamine transporter. Neuron 19, 127138 (1997).
7. Eriksen, J., Jorgensen, T. N. & Gether, U. Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges. J. Neurochem. 113, 2741 (2010).
8. Torres, G. E. et al. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30, 121134 (2001).
9. Standley, S., Roche, K. W., McCallum, J., Sans, N. & Wenthold, R. J. PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron 28, 887898 (2000).
10. Armsen, W., Himmel, B., Betz, H. & Eulenburg, V. The C-terminal PDZ-ligand motif of the neuronal glycine transporter GlyT2 is required for efcient synaptic localization. Mol. Cell Neurosci. 36, 369380 (2007).
11. Kim, E. & Sheng, M. PDZ domain proteins of synapses. Nat. Rev. Neurosci. 5, 771781 (2004).
12. Torres, G. E. et al. Oligomerization and trafcking of the human dopamine transporter. Mutational analysis identies critical domains important for the functional expression of the transporter. J. Biol. Chem. 278, 27312739 (2003).
13. Bjerggaard, C. et al. Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactions. J. Neurosci. 24, 70247036 (2004).
14. Madsen, K. L. et al. Molecular determinants for the complex binding specicity of the PDZ domain in PICK1. J. Biol. Chem. 280, 2053920548 (2005).
15. Ciliax, B. J. et al. The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci. 15, 17141723 (1995).
16. Hersch, S. M., Yi, H., Heilman, C. J., Edwards, R. H. & Levey, A. I. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J. Comp. Neurol. 388, 211227 (1997).
17. Schmidt, L. S. et al. Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice. Psychopharmacology (Berl) 216, 367378 (2011).
18. Eriksen, J. et al. Visualization of dopamine transporter trafcking in live neurons by use of uorescent cocaine analogs. J. Neurosci. 29, 67946808 (2009).
19. Sorkina, T., Doolen, S., Galperin, E., Zahniser, N. R. & Sorkin, A. Oligomerization of dopamine transporters visualized in living cells by uorescence resonance energy transfer microscopy. J. Biol. Chem. 278, 2827428283 (2003).
20. Sorkina, T., Hoover, B. R., Zahniser, N. R. & Sorkin, A. Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Trafc 6, 157170 (2005).
21. Chi, L. & Reith, M. E. Substrate-induced trafcking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations. J. Pharmacol. Exp. Ther. 307, 729736 (2003).
22. Holton, K. L., Loder, M. K. & Melikian, H. E. Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nat. Neurosci. 8, 881888 (2005).
23. Eriksen, J., Bjorn-Yoshimoto, W. E., Jorgensen, T. N., Newman, A. H. & Gether, U. Postendocytic sorting of constitutively internalized dopamine transporter in cell lines and dopaminergic neurons. J. Biol. Chem. 285, 2728927301 (2010).
24. van der Bliek, A. M. et al. Mutations in human dynamin block an intermediate stage in coated vesicle formation. J. Cell Biol. 122, 553563 (1993).
25. Ellgaard, L. & Helenius, A. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 4, 181191 (2003).
26. Sakrikar, D. et al. Attention decit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafcking regulation. J. Neurosci. 32, 53855397 (2012).
27. Rao, A., Simmons, D. & Sorkin, A. Differential subcellular distribution of endosomal compartments and the dopamine transporter in dopaminergic neurons. Mol. Cell Neurosci. 46, 148158 (2011).
28. Perego, C. et al. PDZ-mediated interactions retain the epithelial GABA transporter on the basolateral surface of polarized epithelial cells. EMBO J. 18, 23842393 (1999).
29. Fairless, R. et al. Polarized targeting of neurexins to synapses is regulated by their C-terminal sequences. J. Neurosci. 28, 1296912981 (2008).
30. Farhan, H. et al. Two discontinuous segments in the carboxyl terminus are required for membrane targeting of the rat gamma-aminobutyric acid transporter-1 (GAT1). J. Biol. Chem. 279, 2855328563 (2004).
31. Cubelos, B., Gonzalez-Gonzalez, I. M., Gimenez, C. & Zafra, F. The scaffolding protein PSD-95 interacts with the glycine transporter GLYT1 and impairs its internalization. J. Neurochem. 95, 10471058 (2005).
32. DAmico, A. et al. The surface density of the glutamate transporter EAAC1 is controlled by interactions with PDZK1 and AP2 adaptor complexes. Trafc 11, 14551470 (2010).
33. Jugloff, D. G., Khanna, R., Schlichter, L. C. & Jones, O. T. Internalization of the Kv1.4 potassium channel is suppressed by clustering interactions with PSD-95.J. Biol. Chem. 275, 13571364 (2000).34. Zhang, C. S. et al. Knock-in mice lacking the PDZ-ligand motif of mGluR7a show impaired PKC-dependent autoinhibition of glutamate release, spatial working memory decits, and increased susceptibility to pentylenetetrazol.J. Neurosci. 28, 86048614 (2008).35. Madsen, K. L., Thorsen, T. S., Rahbek-Clemmensen, T., Eriksen, J. & Gether, U. Protein interacting with C kinase 1 (PICK1) reduces reinsertion rates of interaction partners sorted to the RAB11-dependent slow recycling pathway.J. Biol. Chem. 287, 1229312308 (2012).36. Ratjhe, M. A. et al. A PDZ domain library: investigating specicity of PDZ domain small-molecule inhibitors. Program No. 850.18. 2010 Neuroscience Meeting Planner (San Diego, CA: Society for Neuroscience, 2010. Online).
37. Fog, J. U. et al. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51, 417429 (2006).
38. Jaber, M. et al. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur. J. Neurosci. 11, 34993511 (1999).
39. Zhuang, X. et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc. Natl Acad. Sci. USA 98, 19821987 (2001).
12 NATURE COMMUNICATIONS | 4:1580 | DOI: 10.1038/ncomms2568 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2568 ARTICLE
40. Swiatek, P. J. & Gridley, T. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc nger gene Krox20. Genes Dev. 7, 20712084 (1993).
41. Rickhag, M., Deierborg, T., Patel, S., Ruscher, K. & Wieloch, T. Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: inuence of enriched environment. J. Cereb. Blood Flow Metab. 28, 551562 (2008).
42. Biber, K., Klotz, K. N., Berger, M., Gebicke-Harter, P. J. & van Calker, D. Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression. J. Neurosci. 17, 49564964 (1997).
43. Madsen, K. L. et al. Membrane localization is critical for activation of the PICK1 BAR domain. Trafc 9, 13271343 (2008).
44. Thomas-Crusells, J., Vieira, A., Saarma, M. & Rivera, C. A novel method for monitoring surface membrane trafcking on hippocampal acute slice preparation. J. Neurosci. Methods 125, 159166 (2003).
45. Richards, T. L. & Zahniser, N. R. Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens. J. Neurochem. 108, 15751584 (2009).
46. Sorensen, G. et al. Neuropeptide Y Y5 receptor antagonism attenuates cocaine-induced effects in mice. Psychopharmacology (Berl) 222, 565577 (2012).
Acknowledgements
We thank P. Elsman, P. Clausen and L.A. Hansen for excellent technical assistance andA. Fchtbauer for ES cell culture. We thank Professor M. Mller for comments on the manuscript. The work was supported by the National Institute of Health Grants P01 DA
12408 (U.G.), the Danish Medical Research Council (M.R., K.L.M., B.A. and U.G.), University of Copenhagen BioScaRT Program of Excellence (G.S., I.A.J., D.P.D.W., G.W. and U.G.), Lundbeck Foundation Center for Biomembranes in Nanomedicine (U.G. and J.E.), the Lundbeck Foundation (M.R.) the Novo Nordisk Foundation (U.G.) and Fabrikant Vilhelm Pedersen og Hustrus Mindelegat (U.G.).
Author contributions
M.R., F.H.H., G.S., K.N.S., B.A., K.G., K.L.M. and I.V.K. conducted the experiments.I.A.-J., J.E., G.W. and D.P.D.W. provided scientic input. K.N.S., E.-M.F. and J.G. generated knock-in mice. A.H.N. provided the uorescent cocaine analogue JHC 164. M.R., F.H.H., G.S., K.N.S. and U.G. designed the experiments and evaluated the data. M.R., F.H.H., G.S. and U.G. wrote the manuscript.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/naturecommunications
Web End =http://www.nature.com/ http://www.nature.com/naturecommunications
Web End =naturecommunications
Competing nancial interests: The authors declare no competing nancial interests.
Reprints and permission information is available online at http://npg.nature.com/reprintsandpermissions/
Web End =http://npg.nature.com/ http://npg.nature.com/reprintsandpermissions/
Web End =reprintsandpermissions/
How to cite this article: Rickhag, M. et al. A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter. Nat. Commun. 4:1580 doi: 10.1038/ncomms2568 (2013).
NATURE COMMUNICATIONS | 4:1580 | DOI: 10.1038/ncomms2568 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 13
& 2013 Macmillan Publishers Limited. All rights reserved.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Nature Publishing Group Mar 2013
Abstract
The dopamine transporter mediates reuptake of dopamine from the synaptic cleft. The cellular mechanisms controlling dopamine transporter levels in striatal nerve terminals remain poorly understood. The dopamine transporters contain a C-terminal PDZ (PSD-95/Discs-large/ZO-1) domain-binding sequence believed to bind synaptic scaffolding proteins, but its functional significance is uncertain. Here we demonstrate that two different dopamine transporter knock-in mice with disrupted PDZ-binding motifs (dopamine transporter-AAA and dopamine transporter+Ala) are characterized by dramatic loss of dopamine transporter expression in the striatum, causing hyperlocomotion and attenuated response to amphetamine. In cultured dopaminergic neurons and striatal slices from dopamine transporter-AAA mice, we find markedly reduced dopamine transporter surface levels and evidence for enhanced constitutive internalization. In dopamine transporter-AAA neurons, but not in wild-type neurons, surface levels are rescued in part by expression of a dominant-negative dynamin mutation (K44A). Our findings suggest that PDZ-domain interactions are critical for synaptic distribution of dopamine transporter in vivo and thereby for proper maintenance of dopamine homoeostasis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer